Swindon, United Kingdom

Daniel De La Torre

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Daniel De La Torre

Introduction

Daniel De La Torre is a prominent inventor based in Swindon, GB. He has made significant contributions to the field of synthetic genomics, holding two patents that showcase his innovative approach to genetic engineering. His work is characterized by a focus on synthetic prokaryotic genomes, which have the potential to revolutionize various applications in biotechnology.

Latest Patents

Daniel's latest patents include groundbreaking inventions related to synthetic genomes. One of his notable inventions provides a synthetic prokaryotic genome comprising five or fewer occurrences of one or more sense codons. Additionally, he has developed a synthetic prokaryotic genome derived from a parent genome, wherein the synthetic genome comprises less than 10%, 5%, 2%, 1%, 0.5%, or 0.1% of the occurrences of one or more sense codons relative to the parent genome. Furthermore, his work includes a synthetic prokaryotic genome that comprises 100 or more, 200 or more, or 1000 or more genes with no occurrences of one or more sense codons.

Career Highlights

Throughout his career, Daniel has worked with notable organizations such as United Kingdom Research and Innovation and Scarab Genomics, LLC. His experience in these institutions has allowed him to advance his research and contribute to the field of synthetic biology significantly.

Collaborations

Daniel has collaborated with esteemed colleagues, including Julius Fredens and Kaihang Wang. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in synthetic genomics.

Conclusion

Daniel De La Torre is a visionary inventor whose work in synthetic genomics is paving the way for future advancements in biotechnology. His patents reflect a deep understanding of genetic engineering and a commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…